Patents
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
11/2008
11/06/2008CA2683488A1 Use of 4-(nitrooxy)-butyl-(s)-2-(6-methoxy-2-naphtyl)-propanoate for treating pain and inflammation
11/06/2008CA2679658A1 Fusion proteins binding to growth factors
11/06/2008CA2667621A1 Targeted split biomolecular conjugates for the treatment of diseases, malignancies and disorders, and methods of their production
11/05/2008EP1988102A1 Growth factor homolog ZVEGF3
11/05/2008EP1988091A1 Tricyclic compounds
11/05/2008EP1988081A1 Binding inhibitor of sphingosine-1-phosphate
11/05/2008EP1987842A1 Cell proliferation inhibitor
11/05/2008EP1987823A1 Condensation aerosol containing zaleplon for inhalation
11/05/2008EP1987036A1 Hetero-bycyclic antiviral compounds
11/05/2008EP1987032A1 3, 9-diazabicyclo(3.3.1)non-3-yl-aryl methanone derivatives as nicotinic acetylcholine receptor agonists
11/05/2008EP1987031A1 3-heteroaryl- 3,9-diazabicyclo[3.3.1]nonane derivatives as nicotinic acetylcholine receptor agonists
11/05/2008EP1987013A1 Bicyclic sphingosine 1-phosphate analogs
11/05/2008EP1987010A1 Tricyclic n-heteroaryl-carboxamide derivatives containing a benzimidazole unit, method for preparing same and their therapeutic use
11/05/2008EP1987009A1 Cyclourea compounds as calcium channel blockers
11/05/2008EP1986747A2 Quinolones useful as inducible nitric oxide synthase inhibitors
11/05/2008EP1986658A2 Ibandronate new regimen for treating metastatic bone pain
11/05/2008EP1986628A2 Methods and compositions for treating hyperalgesia
11/05/2008EP1986627A2 Use of a compound that enhances gabaa-ergic neurotransmission for the treatment of inflammatory diseases
11/05/2008EP1986621A1 Use of resveratrol and derivatives thereof for promoting the wellness state in mammals
11/05/2008EP1713781B1 Quinazoline derivatives
11/05/2008EP1663970B1 Matrix metalloproteinase inhibitors
11/05/2008EP1487828B1 Morpholinyl-urea derivatives for use of the treatment of inflamatory diseases
11/05/2008EP1465996B1 Raf/ras binding compounds
11/05/2008EP1385514B1 Spiroindene and spiroindane compounds
11/05/2008EP1363937B1 Immunomodulating agents from parasitic worms and method for isolation thereof
11/05/2008EP1341811B9 Orally ingestible preparation of mistletoe lectins and method
11/05/2008EP1309544B1 Compounds acting as melanocortin receptor ligands
11/05/2008EP1216247B1 Imidazoimidazoles and triazoles as anti-inflammatory agents
11/05/2008CN101300259A Tricyclic spiro derivatives as CRTH2 modulators
11/05/2008CN101300255A Imidazolone phenylalanine derivatives as VLA-4 antagonists
11/05/2008CN101300236A Triazole compounds as lipoxygenase inhibitors
11/05/2008CN101300233A Azafused cyclin dependent kinase inhibitors
11/05/2008CN101298481A Inhibitors of complement activation
11/05/2008CN101298440A Pharmaceutical salts of reboxetine
11/05/2008CN101298415A Preparation of non-steroidal anti-inflammatory medicine biphenylacetic acid
11/05/2008CN101297965A Applications of thymic peptide beta4 in preparing medicament for preventing and treating bronchial asthma
11/05/2008CN101297948A Chinese medicine lotion preparation for treating chest wall soft tissue injury
11/05/2008CN101297946A Plaster for activating blood and resolving stasis, dispelling wind and freeing collateral vessels and producing method thereof
11/05/2008CN101297943A Medicinal liquor for strengthening bones and muscles and treating rheumatism
11/05/2008CN101297942A Itch-reliving detumescence agent containing plant vinegar liquid and preparation thereof
11/05/2008CN101297908A Liver-tonifying kidney-boosting medicinal liquor
11/05/2008CN101297896A Method for extracting antipyretic and detoxicated oral liquid using cellulase
11/05/2008CN101297895A Pure Chinese medicinal liquor for treating bone regeneration
11/05/2008CN101297891A Medicinal liquor for activating blood circulation, removing stasis and strengthening spleen
11/05/2008CN101297878A Preparation technique of high-content white peony root effective composition
11/05/2008CN101297877A Preparation of white peony root total glycosides granules
11/05/2008CN101297876A Novel method for preparing white peony root total glycosides extract
11/05/2008CN101297875A Preparation of white peony root total glycosides capsules
11/05/2008CN101297874A Technique for extracting high-content effective composition from white peony root
11/05/2008CN101297841A Compound Tripterygium wilfordii multi-glycosides formulation for curing rheumatic disease and preparation method thereof
11/05/2008CN101297826A Compound Bupleurum injection for curing common cold of dog and preparation thereof
11/05/2008CN101297805A Medicament composition for preventing and controlling enteritis necroticans of domestic birds
11/05/2008CN101297804A Medical use of iso-papaverine
11/05/2008CN101297790A Zaltoprofen sustained-release preparation and preparation thereof
11/05/2008CN101297667A Dandelion health-care tea and preparing process thereof
11/05/2008CN100430383C Benzimidazoles that are useful in treating sexual dysfunction
11/05/2008CN100430067C Carboxylate-gated-nitroxide (CGN) compounds and compositions and methods of use thereof
11/05/2008CN100430052C Cathepsin cysteine protease inhibitors
11/05/2008CN100430048C Alpha-2-delta ligand to treat lower urinary tract symptoms
11/04/2008US7446222 2-benzyloxy-5-chloro-[1,1';2',1'']terphenyl-3''-carboxylic acid; neuropathic pain; chronic articular pain (e.g. rheumatoid arthritis, osteoarthritis, rheumatoid spondylitis, gouty arthritis and juvenile arthritis) including the property of disease modification and joint structure preservation
11/04/2008US7446183 Fusion protein comprising growth hormone and growth hormone receptor
11/04/2008US7446175 Antibodies to human IL-1β
11/04/2008US7446173 amino acid sequence coupled to a non-naturally-occurring polyoxyalkylene glycol at N-terminal end of glycosylated interferon-beta-1a through a coupling group such as aldehyde, maleimide, a vinylsulfone,or haloacetate groups; enhanced activity; Multiple sclerosis; cancer; therapeutical; water solubility
11/04/2008US7446117 Cox-2 inhibiting pyridine derivatives
11/04/2008US7446109 Carbonylamino-derivatives as novel inhibitors of histone deacetylase
11/04/2008US7446106 Pyridylfurans and pyrroles as Raf kinase inhibitors
11/04/2008US7446105 4-(1,2-diethyl-4-methylimidazol-5-yl)-2-{4-[N-(2-methoxyethyl)sulphamoyl]anilino}pyrimidine; selectivity for cyclin-dependent serine/threonine kinases (CDK2, CDK4 and CDK6); antiproliferative agent; minimize pharma toxicity on S-phase cell cycle, G2 or mitosis; oncogene signalling pathways
11/04/2008US7446097 Conjugates of immune cell specific macrolide compounds with anti-inflammatory compounds for improved cellular targeting of anti-inflammatory therapy
11/04/2008US7446091 Methods and preparations for curing clinically ill patients
11/04/2008US7445928 Bacterial artificial chromosome construct encoding recombinant coronavirus
11/04/2008US7445903 Fibrin citrulline derivatives and their use for diagnosing or treating rheumatoid arthritis
11/04/2008US7445780 Antagonistic anti-CD40 antibodies
11/04/2008US7445768 Delivery of sedative-hypnotics through an inhalation route
11/04/2008US7445764 Carrier-drug conjugate
11/04/2008CA2457361C Opioid agonist formulations with releasable and sequestered antagonist
11/04/2008CA2255521C Compositions for treatment of burns
10/2008
10/30/2008WO2008130953A2 2-imin0is0thiaz0le derivatives as cannabinoid receptor ligands
10/30/2008WO2008130879A2 Tetrahydroindole and tetrahydroindazole derivatives
10/30/2008WO2008130323A1 Novel 8-piperazine-tetrahydronaphtalene derivatives for the treatment of pain
10/30/2008WO2008130322A1 Novel 5-heterocyclyl-chromane derivatives for the treatment of pain
10/30/2008WO2008129280A1 Pyrazoles useful in the treatment of inflammation
10/30/2008WO2008129276A1 Disulfonamides useful in the treatment of inflammation
10/30/2008WO2008129270A2 Compositions comprising anti-inflammatory compounds
10/30/2008WO2008129258A1 New use for cannabinoid-containing plant extracts
10/30/2008WO2008129129A1 Heterocyclic phenyl carbamates as novel faah-inhibitors
10/30/2008WO2008129071A1 Inhibitors of protein kinases
10/30/2008WO2008129070A1 Inhibitors of protein kinases
10/30/2008WO2008129069A1 Inhibitors of protein kinases
10/30/2008WO2008128832A1 Nitroderivatives of non-peptidic renin inhibitors for the treatment of cardiovascular, renal and chronic liver disease, inflammations and metabolic syndrome
10/30/2008WO2008128456A1 The functional epitope of osteopontin, the anti-osteoponin monoclonal antibody and use thereof
10/30/2008WO2008128343A1 Boron-containing compounds, uses and preparation thereof
10/30/2008WO2008128321A1 Therapeutic pro-antibiotic agents and methods of use thereof
10/30/2008WO2008109380A3 Nucleic acid compounds for inhibiting vegfr family gene expression and uses thereof
10/30/2008WO2008087323A3 Galenic form for the transmucosal delivery of paracetamol
10/30/2008WO2008074752A3 Indolylmaleimide derivatives as kinase inhibitors
10/30/2008US20080269465 Tumor necrosis factor specific immunoglobulin for use in prevention and treatment of rheumatoid arthritis, ulcerative colitis, multiple sclerosis and crohn's disease
10/30/2008US20080269349 administering an isolated astaxanthin and a mono- or di-ester thereof; controlling cytokine or TGF- alpha -related gene expression; reducing muscle atrophy, treating diabetes
10/30/2008US20080269339 antiinflammatory mixture for treating chronic inflammatory skin disease, not limited to psoriasis; Calcipotriol, Valproic acid, or suberolyanilide hydroxamic acid and ZD1839 (iressa, gefitinib), PD153035, or SU 5271; synergistic effect
10/30/2008US20080269338 Aqueous solutions containing chloramine which are free from di-and trichloroamine, as well as from ammonia
10/30/2008US20080269335 Crth2 Receptor Antagonists